Optimizing medical management in peripheral artery disease. BJS 2018; 105: 1079-1081.

Randomized clinical trial

Authors: H. Djerf, M. Falkenberg, L. Jivegård, H. Lindgren, M. Svensson, J. Nordanstig et al.

Notes: Revascularization effective but pricey

Systematic review

Authors: S. K. Kunutsor, D. Gillatt, A. W. Blom

Notes: Technology with potential

Original article

Authors: R. Mouton, C. A. Rogers, R. A. Harris, R. J. Hinchliffe

Notes: Improves 30‐day survival

Original article

Authors: H. Shiwani, P. Baxter, E. Taylor, M. A. Bailey, D. J. A. Scott

Notes: Non‐linear

Original article

Authors: T. Wallace, J. El‐Sheikha, S. Nandhra, C. Leung, A. Mohamed, A. Harwood et al.

Notes: EVLA lower recurrence at 5 years

Leading article

Authors: A. J. A. Meershoek, G. J. de Borst

Original article

Authors: I. Grootes, J. K. Barrett, P. Ulug, F. Rohlffs, S. J. Laukontaus, R. Tulamo et al.

Notes: Potential to tailor surveillance

Original article

Authors: A. Cervin, H. Ravn, M. Björck

Notes: Diagnosis often delayed

Original article

Authors: B. M. Biccard, A. Sigamani, M. T. V. Chan, D. I. Sessler, A. Kurz, J. G. Tittley et al.

Notes: No evidence to start or stop aspirin

Original article

Authors: K. Heikkila, I. M. Loftus, D. C. Mitchell, A. S. Johal, S. Waton, D. A. Cromwell et al.

Notes: lower than previously estimated